SPOTLIGHT -
EP. 1: SCLC Overview: Presentation, Staging, and Complications
EP. 2: Optimal Management of Limited-Stage SCLC
EP. 3: Addressing the Aggressive Nature of SCLC
EP. 4: Chemoimmunotherapy for ES SCLC: IMpower133 Trial
EP. 5: Chemoimmunotherapy for ES SCLC: CASPIAN Trial
EP. 6: Treatment of Relapsed/Refractory SCLC
EP. 7: Lurbinectedins Role in Managing SCLC
EP. 8: Emerging Treatment Options for SCLC
EP. 9: Small-Cell Lung Cancer: Future Directions in Care
Dr Berkenstock on ADC-Related Ocular Toxicities in Cervical and Ovarian Cancers
Dr Matalonis on the Management of Mirvetuximab Soravtansine-Related Toxicities in FRα+ Ovarian Cancer
Updated EMPOWER-Lung 3 Data Support Frontline Cemiplimab Plus Chemo in Advanced NSCLC
Neoadjuvant Nivolumab Plus Chemotherapy Retains EFS Advantage in Resectable NSCLC
